Phase I study of tolerability and pharmacokinetics of EVT-103
Phase of Trial: Phase I
Latest Information Update: 14 May 2010
At a glance
- Drugs EVT 103 (Primary)
- Indications Depressive disorders
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Evotec AG
- 14 May 2010 Results presented in an Evotec media release, and drug-food interactions added as a descriptor.
- 19 Mar 2010 New trial record
- 10 Mar 2010 Completion of study reported in Evotec media release.